My group's work has centred around the use of nuclear magnetic resonance spectroscopy to study protein structure and function. The most high profile of these are based in areas such as cancer, antibiotics and structure aided drug design that are of central importance to the well being of today’s society.
A major highlight of our recent work has been the solution NMR structure of the domain 11 from the Insulin Growth factor receptor 2 and its interaction with IGF2. This milestone work has paved the way for CRUK and CRT funding (with Prof. Bass Hassan, University of Oxford) and it is an important step along the way to developing a therapeutic receptor to be used in the treatment of several different cancers. This work is currently the major theme within my laboratory alongside the application of NMR for screening potential small ligands for proteins of pharmaceutical interest (funded by UCB).
Finally we increasingly use X-ray crystallography for the structure determination of larger proteins and we have and have over ten collaborative NMR/X-ray projects running in the laboratory (funded by BBSRC, MRC and EPSRC).